Evidence map›Paper›PMID 42909640›Full record

ArticleJournal of neurology2026

The Dutch Mini-Linguistic State Examination (MLSE-NL): findings in Primary Progressive Aphasia (PPA).

Rosie Coppieters, Nikki Janssen, Peter Garrard, Fenna Hiemstra, Annelien Duits, Mattias De Coninck, Stéphanie De Keulenaer, Ian Storey, Vitória Piai, Johan Renssen and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rosie CoppietersExperimental Neurobiology Unit, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0009-0001-7392-2618
Nikki JanssenDepartment of Psychiatry and Medical Psychology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-4866-1954
Peter GarrardDepartment of Neuroscience, City St George's, University of London, London, UK.ORCID http://orcid.org/0000-0001-8268-9718
Fenna HiemstraALS Center Netherlands, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0009-0002-8899-5999
Annelien DuitsDepartment of Psychiatry and Psychology, Maastricht UMC+, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0003-0279-1806
Mattias De ConinckCentrum voor Neuropsychologie, Antwerp, Belgium.ORCID http://orcid.org/0000-0001-5198-9275
Stéphanie De KeulenaerExperimental Neurobiology Unit, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0009-0005-2396-3218
Ian StoreyDepartment of Neuroscience, City St George's, University of London, London, UK.ORCID http://orcid.org/0000-0002-0952-0673
Vitória PiaiDonders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-4860-5952
Johan RenssenDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-2609-1102
Carla RuisDepartment of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-0801-8937
Harro SeelaarDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-1989-7527
Esther van den BergDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8120-7366
Sara Van MosseveldeNeurology Department, Antwerp University Hospital (UZA), Antwerp, Belgium.ORCID http://orcid.org/0000-0002-4403-2958
Rose BruffaertsExperimental Neurobiology Unit, University of Antwerp, Antwerp, Belgium. Rose.Bruffaerts@uantwerpen.be.ORCID http://orcid.org/0000-0002-2631-9234
Lize JiskootDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands. l.c.jiskoot@erasmusmc.nl.ORCID http://orcid.org/0000-0002-1120-1858

Funding

Internationale Stichting Alzheimer Onderzoek Award number 2024
6 · The paper itself

Abstract

state of the artChanges in speech and language occur as the first symptoms of Primary Progressive Aphasia (PPA). The Mini-Linguistic State Examination (MLSE) is a short speech and language screening test used in the diagnostic process of PPA in English-speaking patients. We adapted the MLSE into Dutch (MLSE-NL) and validated this new version as a diagnostic screening tool in Dutch-speaking patients. METHODOLOGY: We assessed the MLSE-NL in 90 Dutch-speaking patients with PPA (nonfluent variant PPA (nfvPPA) n = 23, logopenic variant PPA (lvPPA) n = 24, semantic variant PPA (svPPA) n = 32, PPA Not Otherwise Specified (PPA-NOS) n = 11) (mean age: 68.3, 47.8% male) and 276 healthy volunteers (mean age: 56.3, 38.8% male). The MLSE-NL includes subscores in motor speech, phonological structure, semantic knowledge, syntax, and working memory. Group differences were assessed using Kruskal-Wallis tests, with linear models controlling for covariates as confirmatory analyses.

resultsThe MLSE-NL shows significantly lower scores for all PPA variants for total score, ranging from 30 to 96/100 in patients and 83 to 100/100 in controls. The AUC for total score was 0.99 (subdomain AUCs ranged from 0.80 to 0.92). nfvPPA had more motor speech errors than controls, svPPA had more semantic errors, while lvPPA had the most working memory deficits. Syntax errors were frequent in all variants, while phonological deficits were greater in lvPPA and nfvPPA. PPA-NOS had deficits in all domains aside from motor speech.

conclusionsThe MLSE-NL can successfully discriminate the three canonical variants of PPA and PPA-NOS from controls and captures domain-specific neurolinguistic profiles.

Indexed as

Aphasia, Primary ProgressiveLanguage TestsNeuropsychological TestsAgedFemaleHumansMaleMiddle AgedNetherlandsAphasiaCross-linguisticDementiaDiagnosisNeuropsychologySemantic

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.